The lawsuit, brought forth by the Alliance for Hippocratic Medicine and others, highlights the following concerns:
Removal of safety standards: The FDA removed safeguards for mifepristone and misoprostol, even though its own label states that nearly 1 in 25 women who consume these drugs will end up going to an emergency room.

Increased patient risks: The removal of abortion drug safety standards could lead to a greater number of complications, including hemorrhage, life-threatening infection, and incomplete abortions.

Lack of informed consent: Remote prescription practices and the elimination of in-person doctor visits endanger women, particularly those at risk for ectopic pregnancies.